For those who are treating tickborne illnesses, this excerpt may be particularly of importance to you:
"The drugs reported most frequently to be unavailable or in short supply include the intravenous formulation of trimethoprim/sulfamethoxazole (Bactrim), amikacin (Amikin), aztreonam (Azactam), foscarnet (Foscavir), and penicillin G."
Other drugs are listed as well, of which the shortage will affect many people this flu season as one of them is Tamiflu.
(Now would be a good time for more startups to invest in not only antibiotic drug development, but phage therapy as well.)
MORE on how patients have been affected and why this is happening can be found at the link: http://www.internalmedicinenews.com/newsletter/conference-coverage/singleview40841/id-docs-antimicrobial-shortages-threaten-patient-care-quality/802aeb528c.html
This work by Camp Other is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 3.0 Unported License.